The effects of Intraurethral Stent (Intraurethral Cath) for the Treatment of Benign Prostatic Hypertrophy.
- Author:
Seok Chang JANG
1
;
Won Seok KIM
;
Soo Taek JEONG
;
Tae Joon HA
;
Chang Ha JI
;
Cboong Hee NOH
Author Information
1. Department of Urology, Inje University, Sanggye Paik Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
benign prostatic hypertrophy;
intraurethral stent
- MeSH:
Anesthesia, Epidural;
Cystostomy;
Dysuria;
Humans;
Prostatic Hyperplasia*;
Stents*;
Transurethral Resection of Prostate;
Urinary Bladder;
Urinary Incontinence, Urge;
Urinary Retention
- From:Korean Journal of Urology
1996;37(3):281-285
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Transurethral resection of Prostate(TURP) is the current optimal therapy for benign prostatic hypertrophy. But in some cases of BPH patients, TURP cannot be performed because the patients have medical disorders not to be operated. Thus several alternatives have been used in the management of BPH patients, especially who had anesthetic contraindications to an operation. We experienced 12 cases of BPH patients applied with Intraurethral Cath(IUC) from April 1991 to September 1995. Eleven patients became able to void after IUC insertion. The maximal flow rates were 5.1 to 15.7 ml/sec and average value was 11.8 ml/sec. Almost all patients showed irritative voiding symptoms such as urgency, urge incontinence, frequency, and dysuria at first. In 7 patients, these symptoms disappeared spontaneously within 2 to 5 days and oxybutynin chloride was used orally in 2 patients. Suprapubic cystostomy was done in three patients because two patients had severe irritative voiding symptoms and one patient had persistent urinary retention. The stent was changed every 3 to 6 months. Stone formation around the device was noted in 2 patients and migration of device into the bladder was found in 2 patients. In 4 patients, TURP was performed when the patient's condition improved enough to be operated under epidural anesthesia. In conclusion, the use of IUC is thought to be a valid, cost effective and safe alternative to TURP in the treatment of highly operative risk patients with benign prostatic hypertrophy.
